Sector: Pharmaceuticals & Biotechnology

Mid Cap

Akums Drugs & Pharma Share Price

Akums Drugs & Pharmaceuticals Ltd.

₹474

-4.35(-0.91%)

Invest in AKUMS with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : AKUMS

Open Free Demat Account

Akums Drugs & Pharma Performance

Price Movement

₹474.00

₹468.90

₹482.90

↘ Today's Low↗ Today's High

1 Year Performance

₹474.00

₹405.00

₹622.95

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹482.90

Low₹468.90

Open at₹480.10

Prev Close₹478.35

Volumes1.32 L

Avg Price₹475.07

Lower Circuit₹430.55

Upper Circuit₹526.15

Historical Performance

3M High₹506.00

3M Low₹409.30

1 Yr High₹622.95

1 Yr Low₹405.00

3 Yr High₹1,175.90

3 Yr Low₹405.00

5 Yr High₹1,175.90

5 Yr Low₹405.00

Akums Drugs & Pharma Fundamentals

Market Cap

Above industry Median

7,467.60 Cr.

PE Ratio (TTM)

Above industry Median

23.50

Dividend Yield

Net Profit TTM

113.2% incr over last year

318.19

Net Profit Growth

113.2% incr over last year

318.19

PEG Ratio

Above industry Median

0.20

ROE

2080.4% incr over last year

11.09

Operating Revenue TTM

4,256.70

Operating Revenue Growth

6.2% incr over last year

Book Value

Below industry Median

2.40

MFI

MFI strongly Overbought

83.38

RSI

RSI is mid-range

58.67

EPS (TTM)

22.60

Debt to Equity

Face Value

Operating Profit Margin Qtr.

11.14

Operating Profit Qtr.

146.86

Net Profit Qtr.

66.32

Operating Revenue Qtr.

1,159.59

PB Ratio

2.40

Akums Drugs & Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	368.61	309.32	332.44	328.75	337.41
Operating Expense	343.93	292.42	288.34	311.03	303.38
Operating Profit	24.67	16.89	44.11	17.72	34.03
Depreciation	12.15	10.69	10.25	10.09	10.68
Interest	2.46	2.08	2.91	2.63	2.29
Tax	7.75	7.74	14.64	9.47	13.72
Net Profit	28.11	23.46	44.87	27.59	41.17

Akums Drugs & Pharma Technicals

Akums Drugs & Pharmaceuticals Ltd. EMA & SMA

₹474.00

-4.35 (-0.91%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹478.4

Day EMA10 ₹473.7

Day EMA12 ₹471.5

Day EMA20 ₹464.2

Day EMA26 ₹460.3

Day EMA50 ₹452.6

Day EMA100 ₹455.9

Day EMA200 ₹492.7

Akums Drugs & Pharma Support and Resistance

Resistance

First Resistance₹481.93

Second Resistance₹489.42

Third Resistance₹495.93

Support

First Support₹467.93

Second Support₹461.42

Third Support₹453.93

Technical Indicators

Day RSI58.67

Day MFI83.38

Day ADX27.85

Day Commodity Channel Index58.40

William-47.80

Day MACD11.24

Day MACD Signal Line9.31

Day ATR16.28

Day ROC125-1.17

Day ROC2111.69

Akums Drugs & Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	75.3	75.3	75.3	75.3	75.3	75.3
FII	7.3	6.4	5.8	4.2	2.3	1.1
DII	7.6	7	7.4	8.9	9.3	14.5
Public	7.1	8.6	8.8	8.9	10.5	6.4

Akums Drugs & Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	67.25 K	1.61 L	41.71%
Week	2.95 L	10.7 L	27.56%
1 Month	1.07 L	3.24 L	32.92%
6 Month	1.08 L	2.38 L	45.48%

Akums Drugs & Pharma SWOT Analysis

Strengths17

Weakness3

Opportunity10

Threats1

Benjamin Graham Value Screen

Strong Performer, Under Radar Stocks (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Relative Outperformance versus Industry over 1 Month

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks in uptrend most likely to cross above SMA-200 soon

Stocks Outperforming their Industry Price Change in the Quarter

Akums Drugs & Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Akums Drugs & Pharma Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Alembic Pharmaceuticals Ltd.	Strides Pharma Science Ltd.	Granules India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹774.90	₹872.90	₹598
% Change	3.47%	-5.40%	-0.01%	1.55%	0.37%	-0.18%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹7,266.82	₹4,725.61	₹5,092.46
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹628.95	₹511.44	₹545.48
PE TTM	-	-	62.20	24.00	15.80	26.70
1 Year Return	48.29	6.51	60.63	-4.24	34.18	17.84
ROCE	30.24	34.78	34.76	14.40	19.35	17.24

Similar Stocks

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

SAILIFE

Sai Life Science Ltd.

₹ 968.00

+2.83%

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1320.00

+3.96%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4075.00

+0.75%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

FAQ's on AKUMS

What is the current share price of Akums Drugs & Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Akums Drugs & Pharmaceuticals Ltd. is ₹ 474 on the NSE and ₹ 474 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Akums Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Akums Drugs & Pharmaceuticals Ltd. is approximately ₹ 7467.6 Cr.

What are the PE and PB ratios for Akums Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Akums Drugs & Pharmaceuticals Ltd. is 23.5, and the Price-to-Book (PB) ratio is 2.4.

What is the 52-Week High and Low for Akums Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Akums Drugs & Pharmaceuticals Ltd. shares was ₹ 622.95, and the lowest price was ₹ 405.

Who are the major shareholders of Akums Drugs & Pharmaceuticals Ltd.?

Significant shareholdings in Akums Drugs & Pharmaceuticals Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Akums Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Akums Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.